Chronic arthritis in patients with aspartylglucosaminuria

Journal of Rheumatology

Volumn 25, Issue 6, 1998, Pages 1131-1134

  Arvio, Maria A ^a,b,d   Rapola, Juhani M H ^c   Pelkonen, Pirkko M ^c  

^a Pääjärvi Center   (Finland)

^b RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NONE   (Finland)

Author keywords

Arthritis; Aspartylglucosaminuria; Glycoprotein degradation disorder; Juvenile arthritis; Lysosomal storage disorder; Rheumatoid factor

Indexed keywords

GLYCOPROTEIN; N4 (BETA N ACETYLGLUCOSAMINYL)ASPARAGINASE; RHEUMATOID FACTOR;

ADULT; ARTICLE; ASPARTYLGLYCOSAMINURIA; CHRONIC ARTHRITIS; CLINICAL ARTICLE; ENZYME DEFICIENCY; FEMALE; FINLAND; HUMAN; HUMAN TISSUE; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; LYSOSOME STORAGE DISEASE; MALE; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD;

ACETYLGLUCOSAMINE; ADOLESCENT; ADULT; ARTHRITIS; ASPARTYLGLUCOSYLAMINASE; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FINLAND; HAND; HUMANS; LYSOSOMAL STORAGE DISEASES; LYSOSOMES; MALE; RHEUMATOID FACTOR; STROMAL CELLS; SYNOVIAL MEMBRANE; WRIST; WRIST JOINT;

EID: 0031828264     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Arvio M, Autio S, Louhiala P. Early clinical symptoms and incidence of aspartylglucosaminuria in Finland. Acta Paediatr 1993;82:587-9.
2. Ikonen E, Baumann M, Grön K, et al. Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. EMBO J 1991;1:51-8.
3. Ikonen E, Aula P, Grön K. et al. Spectrum of mutations in aspartylglucosaminuria. Proc Natl Acad Sci USA 1991;88:11222-6.
4. Arvio M. Life with aspartylglucosaminuria [dissertation]. Helsinki: University of Helsinki, 1993.
5. Arvio M, Oksanen V, Autio S, Gaily E, Sainio K. Epileptic seizures in aspartylglucosaminuria - a common disorder. Acta Neurol Scand 1993;87:342-4.
6. Diseases entitled to special reimbursement. National Agency for Medicines and Social Insurance Institution T6:28, Helsinki, 1994.
7. Mäkelä AL. Rheumaregister für JRA in Finnland. Wiss Ztschr Friedrich-Schiller-Univ Jena 1981;30:285-7.
8. Thomas GH, Beaudet AL. Disorders of glycoprotein degradation and structure: alpha-mannosidosis, ß-mannosidosis, fucosidosis, sialidosis, aspartylglucosaminuria and carbohydrate-deficient glycoprotein syndrome. In: Scriver CR, Beaudet AL, Sly WS, et al, editors. The metabolic and molecular basis of inherited disease. New York: McGraw-Hill, 1995:2529-58.
9. Autio S. Aspartylglucosaminuria. Analysis of thirty-four patients. J Mental Deficiency Res, Monograph Series 1;1972:1-39.
10. Weiss SW, Kelly WD. Bilateral destructive synovitis associated with alpha-mannosidase deficiency. Am J Surg Pathol 1983;7:487-94.
11. Näntö-Salonen K. Pelliniemi L, Autio S, et al. Abnormal collagen fibrils in aspartylglucosaminuria. Lab Invest 1984;51:464-8.
12. Määttä A, Järveläinen HT, Nelimarkka LO. et al. Fibroblast expression of collagen and proteoglycans is altered in aspartylglucosaminuria, a lysosomal storage disease. Biochim Biophys Acta 1993;1225:264-70.